TECP

Trails Edge Capital Partners Portfolio holdings

AUM $425M
This Fund
S&P 500
This Quarter Est. Return
1 Year Est. Return
–
3 Year Est. Return
5 Year Est. Return
10 Year Est. Return
AUM
$425M
AUM Growth
+$20.2M
Cap. Flow
Cap. Flow %
Top 10 Hldgs %
Holding
34
New
Increased
Reduced
Closed

Top Buys

1
+$28.4M
2
+$24.7M
3
+$19.1M
4
SNDX icon
Syndax Pharmaceuticals
SNDX
+$15.2M
5
FDMT icon
4D Molecular Therapeutics
FDMT
+$11.3M

Top Sells

1
+$37.9M
2
+$18.4M
3
+$14.9M
4
APGE icon
Apogee Therapeutics
APGE
+$14.5M
5
DFTX
Definium Therapeutics
DFTX
+$14.1M

Sector Composition

1 Healthcare 100%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
PCVX icon
1
Vaxcyte
PCVX
$7.37B
$38.5M 9.06%
662,470
-75,000
DFTX
2
Definium Therapeutics
DFTX
$2.57B
$32.9M 7.73%
1,738,110
-830,000
LBRX
3
LB Pharmaceuticals
LBRX
$797M
$32.5M 7.66%
1,319,362
-76,246
MIRM icon
4
Mirum Pharmaceuticals
MIRM
$5.94B
$30.8M 7.25%
333,312
+301,450
NRIX icon
5
Nurix Therapeutics
NRIX
$1.81B
$27M 6.36%
1,743,220
XENE icon
6
Xenon Pharmaceuticals
XENE
$5.21B
$25.6M 6.02%
440,000
-157,092
RVMD icon
7
Revolution Medicines
RVMD
$32.5B
$23.8M 5.61%
+245,000
RCUS icon
8
Arcus Biosciences
RCUS
$3.01B
$22.6M 5.33%
1,047,935
+131,622
IMCR icon
9
Immunocore
IMCR
$1.45B
$20.6M 4.84%
682,597
CYTK icon
10
Cytokinetics
CYTK
$10.5B
$19.8M 4.65%
+300,000
SNDX icon
11
Syndax Pharmaceuticals
SNDX
$1.74B
$16.4M 3.86%
+701,821
NGNE icon
12
Neurogene
NGNE
$425M
$15.8M 3.71%
782,787
-2,213
IVA
13
Inventiva
IVA
$1.09B
$14.8M 3.47%
2,657,997
IKT icon
14
Inhibikase Therapeutics
IKT
$224M
$13.5M 3.19%
8,057,345
+1,879,221
FDMT icon
15
4D Molecular Therapeutics
FDMT
$463M
$12.1M 2.85%
+1,302,917
XFOR icon
16
X4 Pharmaceuticals
XFOR
$380M
$10.6M 2.5%
2,571,478
IMVT icon
17
Immunovant
IMVT
$6.86B
$10.3M 2.42%
414,054
+173,889
DSGN icon
18
Design Therapeutics
DSGN
$693M
$9.07M 2.13%
+852,013
CAMP icon
19
CAMP4 Therapeutics
CAMP
$219M
$8.55M 2.01%
1,939,563
-44,423
NERV icon
20
Minerva Neurosciences
NERV
$245M
$8.55M 2.01%
+1,419,000
PMN icon
21
ProMIS Neurosciences
PMN
$93.9M
$7.08M 1.67%
+557,103
SLGL icon
22
Sol-Gel Technologies
SLGL
$240M
$6.77M 1.59%
+85,496
IPSC icon
23
Century Therapeutics
IPSC
$417M
$5.54M 1.3%
+2,449,993
VTVT icon
24
vTv Therapeutics
VTVT
$133M
$5.54M 1.3%
139,578
-91,422
SNSE icon
25
Sensei Biotherapeutics
SNSE
$22.3M
$3.94M 0.93%
+125,000
1
2